Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    e7208
Show Display Options
Rank Status Study
1 Recruiting Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Condition: Colorectal Cancer
Interventions: Biological: cetuximab;   Biological: ramucirumab;   Drug: irinotecan hydrochloride

Study has passed its completion date and status has not been verified in more than two years.